ALK and non-small cell lung carcinoma: Given that the majority of patients present late in the disease and, until the very recent past, Stage IV lung cancer has carried an extremely limited and poor prognosis, the rapid progress made in recent years in the understanding and treating of ALK‐positive NSCLC brings promise and hope to all people affected by this condition.